Deciphera Pharmaceuticals, Inc.
NASDAQ:DCPH
25.59 (USD) • At close June 10, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 83.507 | 64.741 | 87.063 | 135.897 | 120.32 | 293.764 | 196.754 | 57.461 | 25.777 |
Short Term Investments
| 222.709 | 259.745 | 198.571 | 416.033 | 459.256 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 306.216 | 324.486 | 285.634 | 551.93 | 579.576 | 293.764 | 196.754 | 57.461 | 25.777 |
Net Receivables
| 31.952 | 22.429 | 20.595 | 13.896 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 21.21 | 20.561 | 14.125 | 5.716 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 21.718 | 25.482 | 18.66 | 12.489 | 13.832 | 7.273 | 1.428 | 0.791 | 0.606 |
Total Current Assets
| 381.096 | 392.958 | 339.014 | 584.031 | 593.408 | 301.037 | 198.182 | 58.252 | 26.383 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 37.494 | 43.254 | 45.41 | 45.924 | 27.491 | 13.453 | 0.838 | 0.514 | 0.387 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 46.699 | 14.55 | 41.95 | 9.375 | 1.51 | 1.069 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 8.277 | 3.277 | 3.11 | 3.102 | 0 | 0 | 0.075 | 0.179 | 0.02 |
Total Non-Current Assets
| 92.47 | 61.081 | 90.47 | 58.401 | 29.001 | 14.522 | 0.913 | 0.693 | 0.407 |
Total Assets
| 473.566 | 454.039 | 429.484 | 642.432 | 622.409 | 315.559 | 199.095 | 58.945 | 26.79 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 26.476 | 18.612 | 13.13 | 12.308 | 19.575 | 8.308 | 4.395 | 1.413 | 1.6 |
Short Term Debt
| 3.504 | 3.235 | 2.87 | 2.457 | 1.747 | 0.187 | 0.187 | 0.187 | 0.187 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 68.35 | 0 | 79.702 | 0 | 0 | 0.194 | 0 | 0 | 0 |
Other Current Liabilities
| 1.945 | 64.622 | 1.071 | 55.227 | 38.716 | 14.054 | 9.233 | 2.957 | 1.263 |
Total Current Liabilities
| 100.275 | 86.469 | 96.773 | 69.992 | 60.038 | 22.937 | 13.815 | 4.557 | 3.05 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 22.375 | 25.879 | 27.991 | 28.764 | 15.904 | 12.641 | 1.294 | 1.481 | 1.679 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0.194 | 0.013 | 192.667 | 137.368 |
Total Non-Current Liabilities
| 22.375 | 25.879 | 27.991 | 28.764 | 15.904 | 12.641 | 1.307 | 194.148 | 139.047 |
Total Liabilities
| 122.65 | 112.348 | 124.764 | 98.756 | 75.942 | 35.578 | 15.122 | 198.705 | 142.097 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 199.095 | 0 | 0 |
Common Stock
| 0.805 | 0.676 | 0.585 | 0.576 | 0.516 | 0.377 | 0.326 | 0 | 0 |
Retained Earnings
| -1,428.305 | -1,233.363 | -1,054.432 | -754.468 | -487.979 | -295.723 | -195.869 | -145.585 | -119.645 |
Accumulated Other Comprehensive Income/Loss
| 0.577 | -0.983 | 0.051 | 0.011 | 0.111 | -1.217 | -0.915 | -0.766 | -0.71 |
Other Total Stockholders Equity
| 1,777.839 | 1,575.361 | 1,358.516 | 1,297.557 | 1,033.819 | 576.544 | 181.336 | 6.591 | 5.048 |
Total Shareholders Equity
| 350.916 | 341.691 | 304.72 | 543.676 | 546.467 | 279.981 | 183.973 | -139.76 | -115.307 |
Total Equity
| 350.916 | 341.691 | 304.72 | 543.676 | 546.467 | 279.981 | 0 | 0 | 0 |
Total Liabilities & Shareholders Equity
| 473.566 | 454.039 | 429.484 | 642.432 | 622.409 | 315.559 | 199.095 | 58.945 | 26.79 |